Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1970 Nov;49(11):2068–2085. doi: 10.1172/JCI106425

Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets

Fletcher B Taylor Jr 1,2, Hans J Müller-Eberhard 1,2
PMCID: PMC535783  PMID: 4248913

Abstract

Dilute whole blood clots were prepared by addition of thrombin to blood diluted 1:10 in phosphate buffer. The pH of this buffer was 7.4 and the ionic strength was 0.084. Though the ionic strength was low, there was no hemolysis of red corpuscles due to the contribution to the osmotic gradient by plasma salts and proteins. In the standard assay the clot was formed by addition of thrombin at 4°C then incubated at 37°C. Retraction and lysis of these clots were inhibited by removal of platelets and by increasing concentrations of purified thrombin. Retraction and lysis were also inhibited by inactivation of any one of the following factors: γM globulin, complement components C4 and 3, and (in the case of lysis) plasminogen.

Evidence that some of the above serum factors were adsorbed to the platelet membrane was obtained by aggregation of washed platelets by antisera to these factors (i.e. fibrinogen, γM, and C4 or C3). These platelets were not aggregated by antisera to other serum proteins (by albumin, transferrin, γG globulin).

These and other studies suggested that platelets, thrombin, fibrinogen, γM globulin (cold agglutinin), complement components, and plasminogen influenced and facilitated retraction and lysis of clots. These studies also suggested that platelets and some of these factors were physically associated.

Because of this physical association, and because of the fact that clot retraction is associated with aggregation and retraction of platelets, we extended the above observations to include a study of the effect of these same serum factors on serum-induced aggregation and retraction of washed platelets. (Other terms which have been in use in the past to describe serum-induced platelet aggregation and retraction have included those such as platelet “fusion” and “viscous metamorphosis,” neither of which fully described the phenomena.)

Platelet aggregation and retraction induced by serum was markedly accelerated by addition of increasing concentrations of thrombin and (or) cold agglutinin. Hirudin and antisera to γM globulin inhibited seruminduced aggregation and retraction of platelets. Reconstitution of inactivated serum with purified C4, 3, and 5 and thrombin restored its capacity to induce aggregation and retraction of platelets.

Therefore, we postulated that platelet aggregation and retraction were necessary for clot retraction and that platelet aggregation and clot retraction facilitated clot lysis. More specifically we postulated that thrombin, in addition to catalyzing clot formation, also modified the platelet membrane such that γM globulin (cold agglutinin) and complement components can act on the platelet membrane leading to (a) aggregation and retraction of the platelets, (b) retraction of the clot, and (c) to the activation of plasminogen either on the surface of the platelet by C8i and (or) by release of platelet activators of plasminogen.

Full text

PDF
2072

Images in this article

2075Image
on p.2075
2076Image
on p.2076
2078Image
on p.2078
2079Image
on p.2079
2080Image
on p.2080
2081Image
on p.2081

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BICKFORD A. F., Jr, TAYLOR F. B., Jr ROLE OF PLATELETS IN DISSOLUTION OF BLOOD CLOTS. Nature. 1963 Aug 10;199:610–611. doi: 10.1038/199610a0. [DOI] [PubMed] [Google Scholar]
  2. Brown M. E., Rothstein F. Fibrinogen from human plasma: preparation by precipitation with heavy-metal coordination complex. Science. 1967 Feb 24;155(3765):1017–1019. doi: 10.1126/science.155.3765.1017. [DOI] [PubMed] [Google Scholar]
  3. COHEN S. I., WARREN R. Fibrinolysis. N Engl J Med. 1961 Jan 12;264:79–contd. doi: 10.1056/NEJM196101122640206. [DOI] [PubMed] [Google Scholar]
  4. DACIE J. V. The presence of cold haemolysins in sera containing cold haemagglutinins. J Pathol Bacteriol. 1950 Apr;62(2):241–257. doi: 10.1002/path.1700620212. [DOI] [PubMed] [Google Scholar]
  5. DAVIS B. J. DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS. Ann N Y Acad Sci. 1964 Dec 28;121:404–427. doi: 10.1111/j.1749-6632.1964.tb14213.x. [DOI] [PubMed] [Google Scholar]
  6. FEARNLEY G. R., BALMFORTH G., FEARNLEY E. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci. 1957 Nov;16(4):645–650. [PubMed] [Google Scholar]
  7. Gross R. Platelet enzymes. Thromb Diath Haemorrh Suppl. 1967;26:143–154. [PubMed] [Google Scholar]
  8. HAINES A. L., LEPOW I. H. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES. J Immunol. 1964 Mar;92:456–467. [PubMed] [Google Scholar]
  9. HOLEMANS R., GROSS R. Influence of blood platelets on fibrinolysis. Thromb Diath Haemorrh. 1961 Sep 1;6:196–214. [PubMed] [Google Scholar]
  10. HOUGIE C., AYERS F. Lipaemia and fibrinolytic potentiality. Lancet. 1960 Jan 23;1(7117):186–188. doi: 10.1016/s0140-6736(60)90108-2. [DOI] [PubMed] [Google Scholar]
  11. MUELLER-EBERHARD H. J., BIRO C. E. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1963 Sep 1;118:447–466. doi: 10.1084/jem.118.3.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. MULLER-EBERHARD H. J., NILSSON U., ARONSSON T. Isolation and characterization of two beta1-glycoproteins of human serum. J Exp Med. 1960 Feb 1;111:201–215. doi: 10.1084/jem.111.2.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Müllerèberhard H. J., Dalmasso A. P., Calcott M. A. The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis. J Exp Med. 1966 Jan 1;123(1):33–54. doi: 10.1084/jem.123.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. NACHMAN R. L. IMMUNOLOGIC STUDIES OF PLATELET PROTEIN. Blood. 1965 May;25:703–711. [PubMed] [Google Scholar]
  15. NILSSON U. R., MUELLER-EBERHARD H. J. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 Aug 1;122:277–298. doi: 10.1084/jem.122.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. NISHIOKA K. Measurements of complement by agglutination of human erythrocytes reacting in immune-adherence. J Immunol. 1963 Jan;90:86–97. [PubMed] [Google Scholar]
  17. NORMAN P. S. Studies of the plasmin system. I. Measurement of human and animal plasminogen; measurement of an activator in human serum. J Exp Med. 1957 Sep 1;106(3):423–437. doi: 10.1084/jem.106.3.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Taylor F. B., Jr, Botts J. Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen. Biochemistry. 1968 Jan;7(1):232–242. doi: 10.1021/bi00841a028. [DOI] [PubMed] [Google Scholar]
  20. Taylor F. B., Jr, Staprans I. Chromatography, physical characteristics, and disulfide bonds of euglobulin plasminogen. Arch Biochem Biophys. 1966 Apr;114(1):38–49. doi: 10.1016/0003-9861(66)90302-x. [DOI] [PubMed] [Google Scholar]
  21. Taylor F. B., Müller-Eberhard H. J. Factors influencing lysis of whole blood clots. Nature. 1967 Dec 9;216(5119):1023–1025. doi: 10.1038/2161023a0. [DOI] [PubMed] [Google Scholar]
  22. Weiss H. J. Platelet aggregation, adhesion and adenosine diphosphate release in thrombopathia (platelet factor 3 deficiency). A comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am J Med. 1967 Oct;43(4):570–578. doi: 10.1016/0002-9343(67)90180-5. [DOI] [PubMed] [Google Scholar]
  23. ZUCKER M. B., BORRELLI J. Some effects of divalent cations on the clotting mechanism and the platelets of EDTA blood. J Appl Physiol. 1958 May;12(3):453–460. doi: 10.1152/jappl.1958.12.3.453. [DOI] [PubMed] [Google Scholar]
  24. Zucker M. B., Pert J. H., Hilgartner M. W. Platelet function in a patient with thrombasthenia. Blood. 1966 Oct;28(4):524–534. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES